Skip to main content

Table 1 Clinical data

From: Comparison of alterations in cerebral hemoglobin oxygenation in late life depression and Alzheimer’s disease as assessed by near-infrared spectroscopy

 

Controls

Depression

Alzheimer’s Disease

Statistics

Post hoc comparisons

 

(n = 33)

(n = 30)

(n = 28)

D vs AD

D vs HC

AD vs HC

Male:Female

11:22

9:21

10:18

χ2 = 0.22, df = 2, p = 0.90

   

Age (years)

69.6 ± 5.5

71.1 ± 6.8

76.6 ± 6.9

F = 9.66 p < 0.001

p = 0.005

p = 0.603

p < 0.001

MMSE score

29.2 ± 1.2

26.6 ± 2.3

21.6 ± 4.4

F = 52.7 p < 0.001

p < 0.001

p = 0.002

p < 0.001

FAB score

16.1 ± 1.2

14.1 ± 2.7

12.0 ± 3.2

F = 20.1 p < 0.001

p = 0.008

p = 0.005

p < 0.001

CDR score

0

0.05 ± 0.2

0.8 ± 0.4

p < 0.001

p < 0.001

p = 0.065

p < 0.001

HAMD score

0.2 ± 0.8

10.7 ± 8.9

4.4 ± 7.1

F = 20.3 p < 0.001

p = 0.001

p < 0.001

p = 0.037

VFT performance

41.3 ± 7.9

33.2 ± 12.2

33.9 ± 10.1

F = 6.19 p = 0.003

p = 0.963

p = 0.006

p = 0.015

Benton Judgment of Line Orientation performance

22.6 ± 6.6

12.5 ± 4.2

13.7 ± 8.5

F = 21.6 p < 0.001

p = 0.779

p < 0.001

p < 0.001

  1. Continuous values are shown as the means ± standard deviation. Abbreviations: AD Alzheimer’s disease, CDR Clinical Dementia Rating, D depression, df degrees of freedom, FAB Frontal Assessment Battery, HAMD Hamilton Rating Scale for Depression, HC healthy controls, MMSE Mini Mental State Examination, χ2 Chi-squared value.